Brandinium

Trademark search for:

GLYGENTRO

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-03-03 — Application filed
  • 2023-03-07 — Application filed
  • 2023-03-24 — Application filed
  • 2023-09-21 — Assigned to examiner
  • 2023-09-24 — Final disposition recorded
  • 2023-09-24 — Final disposition recorded
  • 2023-09-24 — Final disposition recorded
  • 2023-10-24 — Office action issued
  • 2023-10-24 — Correspondence received in law office
  • 2023-10-25 — Teas/email correspondence entered
  • 2023-10-26 — Approved for pub - principal register
  • 2023-11-08 — Notification of notice of publication e-mailed
  • 2023-11-28 — Published for opposition
  • 2023-11-28 — Official gazette publication confirmation e-mailed
  • 2024-01-23 — Noa e-mailed - sou required from applicant
  • 2024-05-24 — Sou teas extension received
  • 2024-05-24 — Sou extension 1 filed
  • 2024-05-24 — Sou extension 1 granted
  • 2024-08-02 — Teas withdrawal of attorney received-firm retains
  • 2024-08-02 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-08-02 — Teas change of correspondence received
  • 2024-08-02 — Attorney/dom.rep.revoked and/or appointed
  • 2024-12-17 — Sou extension 2 granted
  • 2024-12-17 — Sou teas extension received
  • 2024-12-17 — Sou extension 2 filed
  • 2025-03-03 — Notice of approval of extension request e-mailed
  • 2025-08-25 — Application abandoned
  • 2025-08-25 — Application abandoned
  • 2025-08-25 — Final status recorded

Owner Information

Ultragenyx Pharmaceutical Inc.
Novato , CA
Ultragenyx Pharmaceutical Inc.
Novato , CA

Correspondent

Brian Focarino Cooley LLP
1299 Pennsylvania Avenue, NW, Suite 700
ATTN: IP Docketing Department
Washington, DC 20004-2400

Filing Details

Filing Date:
2023-03-03
Status Date:
2025-08-25
Category:
Pharmaceuticals
Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.